PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

MeiraGTx Holdings plc

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from MeiraGTx Holdings plc's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Tangible Assets Ratio: Of every $100 the company owns, $100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 95% of Healthcare companies in United States.

Where $100 of sales goes

$230Operating costs$15Interest$140Net loss

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

-8.7×

Over the last 3 years operating cash was negative while the company kept spending on investment (capex).

Higher than 51% of Healthcare companies in United States.

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

2/3 · 2/3

Sales grew in 2 of the last 3 years; profit grew in 2 of 3.

Steadier than 69% of Healthcare companies in United States.

Growth Efficiency Ratio

$24

Sales grew 411% in 3 years; of every extra $100 of sales, $24 became extra profit.

Higher than 54% of Healthcare companies in United States.

Asset Productivity Ratio

+411% / -23%

In 3 years sales changed by +411% while total assets changed by -23%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

-1.9×

Operating cash was negative last year, while some debt falls due within a year.

Higher than 64% of Healthcare companies in United States.

Cash Cushion Ratio

−2%

Debt, after subtracting cash, equals 2% of its market value (net debt).

Lower than 71% of Healthcare companies in United States.

Tangible Assets Ratio

100%

Of every $100 the company owns, $100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 95% of Healthcare companies in United States.

Tangible Net Worth Ratio

—

Data incomplete

Shareholders

Shareholder Slice Ratio

+67%

Share count rose 67% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 62% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

MeiraGTx Holdings plc owes $0.46 for every $1 it owns. MeiraGTx Holdings plc made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

11.2

Investors pay $11.2 for every $1 of MeiraGTx Holdings plc's yearly profit, lower than 79% of Healthcare companies in United States.

P/B ratio

4.35

The share price is 4.35 times MeiraGTx Holdings plc's book value per share, higher than 68% of Healthcare companies in United States.

Market cap

$938 M

The total market value of all of MeiraGTx Holdings plc's shares at today's price (share price × number of shares), larger than 63% of Healthcare companies in United States. PosiCap size class: Mini Cap.

Net worth (book value)

$216 M

What MeiraGTx Holdings plc would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$2.24

Net worth divided by the number of shares. The share price of $9.77 is 4.4 times this, which is the P/B above.

Return on equity (ROE)

72.2%

MeiraGTx Holdings plc earned 72.2% on its shareholders' money over the last year, higher than 98% of Healthcare companies in United States.

Owes vs Owns

0.46×

MeiraGTx Holdings plc owes $0.46 for every $1 it owns (low), higher than 52% of Healthcare companies in United States.

Dividend yield

None

MeiraGTx Holdings plc does not currently pay a dividend.

Revenue growth

+145%

Revenue rose 145% in the year to Dec 2025, and grew 72% a year on average over 3 years.

Profit growth

Loss

MeiraGTx Holdings plc made a loss in each of the last two years.

Profit margin

-140.3%

MeiraGTx Holdings plc lost $140 for every $100 of revenue.

Interest cover

Not covered

MeiraGTx Holdings plc's operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net debt

MeiraGTx Holdings plc had $23 M more debt than cash (net debt) at Dec 2025.

Questions

What is MeiraGTx Holdings plc's P/E ratio?

Investors pay $11.2 for every $1 of MeiraGTx Holdings plc's yearly profit, lower than 79% of Healthcare companies in United States.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For MeiraGTx Holdings plc: $938 M ÷ $216 M (30 Jun 2026) = 4.4.

What is MeiraGTx Holdings plc's return on equity?

MeiraGTx Holdings plc earned 72.2% on its shareholders' money over the last year, higher than 98% of Healthcare companies in United States.

How much does MeiraGTx Holdings plc owe compared with what it owns?

MeiraGTx Holdings plc owes $0.46 for every $1 it owns (low), higher than 52% of Healthcare companies in United States.

Does MeiraGTx Holdings plc pay a dividend?

No. MeiraGTx Holdings plc does not currently pay a dividend.

Is MeiraGTx Holdings plc's revenue growing?

Revenue rose 145% in the year to Dec 2025, and grew 72% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.